Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism
Open Access
- 15 May 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (10), 3876-3882
- https://doi.org/10.1182/blood-2005-07-3043
Abstract
Depolymerized holothurian glycosaminoglycan (DHG) is a fucosylated chrondroitin sulfate that possesses antithrombin-independent antithrombotic properties and inhibits factor X activation by the intrinsic tenase complex (factor IXa–factor VIIIa). The mechanism and molecular target for intrinsic tenase inhibition were determined and compared with inhibition by low-molecular-weight heparin (LMWH). DHG inhibited factor X activation in a noncompetitive manner (reduced Vmax(app)), with 50-fold higher apparent affinity than LMWH. DHG did not affect factor VIIIa half-life or chromogenic substrate cleavage by factor IXa–phospholipid but reduced the affinity of factor IXa for factor VIIIa. DHG competed factor IXa binding to immobilized LMWH with an EC50 35-fold lower than soluble LWMH. Analysis of intrinsic tenase inhibition, employing factor IXa with mutations in the heparin-binding exosite, demonstrated that relative affinity (Ki) for DHG was as follows: wild type > K241A > H92A > R170A > > R233A, with partial rather than complete inhibition of the mutants. This rank order for DHG potency correlated with the effect of these mutations on factor IXa–LMWH affinity and the potency of LMWH for intrinsic tenase. DHG also accelerated decay of the intact intrinsic tenase complex. Thus, DHG binds to an exosite on factor IXa that overlaps with the binding sites for LMWH and factor VIIIa, disrupting critical factor IXa–factor VIIIa interactions.This publication has 51 references indexed in Scilit:
- Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or PentasaccharideOnline Journal of Public Health Informatics, 2003
- Heparin and Calcium Ions Dramatically Enhance Antithrombin Reactivity with Factor IXa by Generating New Interaction ExositesBiochemistry, 2003
- Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure modelKidney International, 2003
- Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complexBlood, 2002
- The Contribution of Factor Xa to Exosite-dependent Substrate Recognition by ProthrombinaseOnline Journal of Public Health Informatics, 2002
- Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismThe New England Journal of Medicine, 1997
- Model for the Factor VIIIa-dependent Decay of the Intrinsic Factor XaseOnline Journal of Public Health Informatics, 1996
- The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IXOnline Journal of Public Health Informatics, 1996
- Heparin in thrombosis and embolismBritish Journal of Surgery, 1940